title: Importance of a multidisciplinary approach for the treatment of Barrett's esophagus.
abstract: Barrett's esophagus is a consequence of gastroesophageal reflux disease. Today, it is the most common cause of esophageal adenocarcinoma. Cancer is usually the end results of a cascade of events whereby metaplasia changes into low- and high-grade dysplasia and eventually cancer. Today, we have the unique opportunity to block this cascade and avoid the development of esophageal cancer. A multidisciplinary approach with a team composed of radiologists, gastroenterologists, pathologists, and surgeons allows individualization of care and the best results.
authors.affiliation: Department of Surgery, Institute of Clinical Surgery, University of Ferrara and University Hospital of Ferrara, Italy.
authors.forename: Carlo V
authors.initials: CV
authors.lastname: Feo
authors.forename: Marco G
authors.initials: MG
authors.lastname: Patti
mesh_terms: D000230:Adenocarcinoma / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D001471:Barrett Esophagus / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D017115:Catheter Ablation; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D004945:Esophagoscopy; D018662:Fundoplication; D005764:Gastroesophageal Reflux / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D011230:Precancerous Conditions / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors